Home  »  Markets   »  ProKidney Corp. (PROK) Review – Making Smart...

ProKidney Corp. (PROK) Review – Making Smarter Decisions

ProKidney Corp. (NASDAQ: PROK) is -2.93% lower on its value in year-to-date trading and has touched a low of $6.19 and a high of $14.00 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The PROK stock was last observed hovering at around $9.11 in the last trading session, with the day’s gains setting it 0.5%.

Currently trading at $9.61, the stock is -7.06% and -3.39% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.25 million and changing 5.49% at the moment leaves the stock 0.64% off its SMA200. PROK registered -2.93% loss for a year compared to 6-month gain of -2.24%.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free.


The stock witnessed a -5.78% loss in the last 1 month and extending the period to 3 months gives it a 28.13%, and is -8.04% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 17.17% over the week and 9.46% over the month.

Distance from 52-week low is 55.25% and -31.36% from its 52-week high.

ProKidney Corp. (PROK) Analyst Forecasts

Analyst recommendations provided by FactSet shows that the consensus forecast for ProKidney Corp. (PROK) is a “Overweight”. 4 analysts offering their recommendations for the stock have an average rating of 1.80, where 1 rate it as a Hold and 0 think it is a “Overweight”. 3 of the analysts rate the stock as a “Buy”. 0 analysts have rated the stock as a Sell or Underperform.

ProKidney Corp. is expected to release its quarterly report on 03/01/2023.

ProKidney Corp. (PROK) Top Institutional Holders

The shares outstanding are 232.75M, and float is at 35.24M with Short Float at 0.44%.

ProKidney Corp. (PROK) Insider Activity

A total of 13 insider transactions have happened at ProKidney Corp. (PROK) in the last six months, with sales accounting for 2 and purchases happening 11 times. The most recent transaction is an insider purchase by Cowen Aaron, the company’s 10% Owner. SEC filings show that Cowen Aaron bought 7,007 shares of the company’s common stock on Sep 06 at a price of $6.99 per share for a total of $48979.0. Following the purchase, the insider now owns 6.28 million shares.

ProKidney Corp. disclosed in a document filed with the SEC on Aug 31 that Cowen Aaron (10% Owner) bought a total of 3,162 shares of the company’s common stock. The trade occurred on Aug 31 and was made at $8.94 per share for $28258.0. Following the transaction, the insider now directly holds 6.27 million shares of the PROK stock.

Still, SEC filings show that on Aug 30, Cowen Aaron (10% Owner) acquired 706 shares at an average price of $7.49 for $5288.0. The insider now directly holds 6,270,006 shares of ProKidney Corp. (PROK).

Most Popular

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Related Posts

Receive Best Stock To Trade Before The Opening Bell



100% Free. Stop Anytime. No Spam




The 5 Best Inflation Stocks for 2022

100% free. stop anytime no spam

Get our free report on the stocks that we recommend for investors who want to protect their portfolios from inflation.